This week, we’ll review recommendations from a new guideline issued by the American Cancer Society on cervical cancer screening. Then, we’ll discuss the FDA’s approval of a triplet therapy for advanced melanoma. Lastly, we’ll hear a summary of a panel discussion on telehealth for patients with cancer during the COVID-19 pandemic.

Coverage of stories discussed this week on ascopost.com:

American Cancer Society Updates Guideline for Cervical Cancer Screening

FDA Approves Atezolizumab Plus Cobimetinib/Vemurafenib for Advanced

BRAF V600–Mutated Melanoma